Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masoud Shekarabi

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Scientific Reports|November 4, 2018
Dysregulation of Neuronal Cholesterol Homeostasis upon Exposure to HIV-1 Tat and Cocaine Revealed by RNA-SequencingTaha Mohseni Ahooyi, Masoud Shekarabi, Bahareh Torkzaban, et al.
Annals of Neurology|September 30, 2004
A mutation in the HSN2 gene causes sensory neuropathy type II in a Lebanese familyJean-Baptiste Rivière, Dominique J Verlaan, Masoud Shekarabi, et al.
Plos One|June 1, 2013
Potassium-chloride cotransporter 3 interacts with Vav2 to synchronize the cell volume decrease response with cell protrusion dynamicsAdèle Salin-Cantegrel, Masoud Shekarabi, Sarah Rasheed, et al.
Human Molecular Genetics|June 21, 2008
HMSN/ACC truncation mutations disrupt brain-type creatine kinase-dependant activation of K+/Cl- co-transporter 3Adèle Salin-Cantegrel, Masoud Shekarabi, Sébastien Holbert, et al.
Molecular Therapy. Nucleic Acids|March 5, 2019
RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and ReplacementAida Abu-Baker, Nawwaf Kharma, Jonathan Perreault, et al.
The Journal of Biological Chemistry|June 2, 2011
Transit defect of potassium-chloride Co-transporter 3 is a major pathogenic mechanism in hereditary motor and sensory neuropathy with agenesis of the corpus callosumAdèle Salin-Cantegrel, Jean-Baptiste Rivière, Masoud Shekarabi, et al.
The Journal of Clinical Investigation|June 4, 2008
Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type IIMasoud Shekarabi, Nathalie Girard, Jean-Baptiste Rivière, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 17, 2012
Loss of neuronal potassium/chloride cotransporter 3 (KCC3) is responsible for the degenerative phenotype in a conditional mouse model of hereditary motor and sensory neuropathy associated with agenesis of the corpus callosumMasoud Shekarabi, Randal X Moldrich, Sarah Rasheed, et al.
American Journal of Human Genetics|August 9, 2011
KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2Jean-Baptiste Rivière, Siriram Ramalingam, Valérie Lavastre, et al.
American Journal of Human Genetics|March 8, 2011
Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disabilityFadi F Hamdan, Julie Gauthier, Yoichi Araki, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Scientific Reports|November 4, 2018
Dysregulation of Neuronal Cholesterol Homeostasis upon Exposure to HIV-1 Tat and Cocaine Revealed by RNA-SequencingTaha Mohseni Ahooyi, Masoud Shekarabi, Bahareh Torkzaban, et al.
Annals of Neurology|September 30, 2004
A mutation in the HSN2 gene causes sensory neuropathy type II in a Lebanese familyJean-Baptiste Rivière, Dominique J Verlaan, Masoud Shekarabi, et al.
Plos One|June 1, 2013
Potassium-chloride cotransporter 3 interacts with Vav2 to synchronize the cell volume decrease response with cell protrusion dynamicsAdèle Salin-Cantegrel, Masoud Shekarabi, Sarah Rasheed, et al.
Human Molecular Genetics|June 21, 2008
HMSN/ACC truncation mutations disrupt brain-type creatine kinase-dependant activation of K+/Cl- co-transporter 3Adèle Salin-Cantegrel, Masoud Shekarabi, Sébastien Holbert, et al.
Molecular Therapy. Nucleic Acids|March 5, 2019
RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and ReplacementAida Abu-Baker, Nawwaf Kharma, Jonathan Perreault, et al.
The Journal of Biological Chemistry|June 2, 2011
Transit defect of potassium-chloride Co-transporter 3 is a major pathogenic mechanism in hereditary motor and sensory neuropathy with agenesis of the corpus callosumAdèle Salin-Cantegrel, Jean-Baptiste Rivière, Masoud Shekarabi, et al.
The Journal of Clinical Investigation|June 4, 2008
Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type IIMasoud Shekarabi, Nathalie Girard, Jean-Baptiste Rivière, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 17, 2012
Loss of neuronal potassium/chloride cotransporter 3 (KCC3) is responsible for the degenerative phenotype in a conditional mouse model of hereditary motor and sensory neuropathy associated with agenesis of the corpus callosumMasoud Shekarabi, Randal X Moldrich, Sarah Rasheed, et al.
American Journal of Human Genetics|August 9, 2011
KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2Jean-Baptiste Rivière, Siriram Ramalingam, Valérie Lavastre, et al.
American Journal of Human Genetics|March 8, 2011
Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disabilityFadi F Hamdan, Julie Gauthier, Yoichi Araki, et al.
Pageof 3